Diagnos Laboratorium Utama Tbk. vs Unilever Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Unilever Indonesia Tbk. trades at Rp1,670 (market cap 63.9T, 9.09M 24h volume). The key difference: Unilever Indonesia Tbk. is far larger — about 205.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Unilever Indonesia Tbk. is more actively traded (9.09M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | UNVR | |
|---|---|---|
Market Cap | 310.75B | 63.9T |
Volume | 963.6K | 9.09M |
Lot | 9.64K | 90.94K |
Turnover | 217.67M | 15.25B |
Average Price | 225.89 | 1,677.47 |
Value | 217.67M | 15.25B |
Indicative Equilibrium Price | 226 | 1,670 |
Indicative Equilibrium Volume | 1K | 3.26K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Read more on UNVR →